• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Hvivo PLC (HVO)

ORD 0.1P
Sell: 6.40p|Buy: 6.80p|Change: 0.60 (10.00%)

Open 

6.05p

Previous close 

6.00p

Trade high 

6.50p

Volume 

1,856,041

Year high 

11.00p

Year low 

4.305p

Dividend yield 

–

Market capitalisation 

£45.43 mn

P/E ratio 

11.30

ISIN 

GB00B9275X97

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Share price

Dividends

PreviousLatest
Record date19/04/202416/05/2025
Ex-dividend date18/04/202415/05/2025
Payment date20/05/202411/06/2025
Amount0.20p0.20p

Performance 23/09/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Hvivo PLC+ 10.00
FTSE AIM All Share+ 0.06
More...

Company profile

hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infectious and respiratory indications. It also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its subsidiary, it provides early-phase clinical trial services and Early Drug DevelopmentConsulting and Biometry services to the biopharma sector. It provides development solutions from preclinical stages through Phase II trials, via FluCamp. Geographically, the company generates maximum revenue from Europe, followed by North America, the United Kingdom, and Asia.

Sector 

Healthcare

News

Recent trades

DateTimePriceQuantityValue (£)
23/09/202604:04:136.477516,7931,087.77
23/09/202604:02:006.477518,0001,165.95
23/09/202603:45:236.47759,400608.89
23/09/202603:38:526.525,0001,625.00
23/09/202603:38:466.45110,000645.10

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.